Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News TCT 2021

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

Yael L. Maxwell

November 05, 2021

News Conference News TCT 2021

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Todd Neale

November 05, 2021

News Conference News TCT 2020

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

Todd Neale

October 17, 2020

Presentation TCT 2020

TRANSIT: Treatment of Failed TAVR With TAVR

Presenter: Luca Testa

October 17, 2020

Presentation JIM 2019

How to approach bicuspid aortic stenosis: sizing, valve type and implantation

Presenter: Luca Testa

February 15, 2019

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

Presentation EuroPCR 2017

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

Presenter: Luca Testa

May 19, 2017

News Conference News EuroPCR 2017

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

Caitlin E. Cox

May 17, 2017

News Daily News

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

Jason Kahn

January 16, 2014

News Daily News

La Anomalía en la Condución secundaria a la TAVR Empeora el Estado Funcional, No la Mortalidad

Jason Kahn

January 16, 2014

News Daily News

中度/重度二尖瓣返流TAVR患者的预后更差

October 11, 2013

News Daily News

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

October 11, 2013

News Daily News

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

October 11, 2013

News Daily News

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

February 28, 2013

News Daily News

El BRIHH Persistente tras la Implantación de un Dispositivo CoreValve se asoció a la Necesidad de tener que Implantar un Marcapaso

February 28, 2013

Presentation

Clinical Impact of Persistent LBBB After TAVR with CoreValve Revalving System

Presenter: 127662|Luca Testa

February 27, 2013

Advertisement

TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3

SURTAVI: Self-Expanding TAVI Valve Holds Up vs SAVR Through 5 Years

Encouraging Results Seen for TAVR in Failed Surgical or TAVR Valves

TRANSIT: Treatment of Failed TAVR With TAVR

How to approach bicuspid aortic stenosis: sizing, valve type and implantation

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Prosthesis-Related Events and Echocardiographic Data Throughout 9 Years Follow Up After TAVI

TAVR Durability: Some Reassurances From CoreValve Trials Out to 9 Years

TAVR-Linked Conduction Abnormality Worsens Functional Status, but Not Mortality

La Anomalía en la Condución secundaria a la TAVR Empeora el Estado Funcional, No la Mortalidad

中度/重度二尖瓣返流TAVR患者的预后更差

TAVR Patients with Moderate/Severe Mitral Regurgitation Carry Worse Prognosis

Los Pacientes TAVR con Regurgitación Mitral Moderada/Severa tienen un Peor Pronóstico

Persistent LBBB After CoreValve Implantation Associated With Need for Pacemaker

El BRIHH Persistente tras la Implantación de un Dispositivo CoreValve se asoció a la Necesidad de tener que Implantar un Marcapaso

Clinical Impact of Persistent LBBB After TAVR with CoreValve Revalving System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content